The role of mechano-regulated YAP/TAZ in erectile dysfunction
Abstract Phosphodiesterase type 5 inhibitors (PDE5is) constitute the primary therapeutic option for treating erectile dysfunction (ED). Nevertheless, a substantial proportion of patients, approximately 30%, do not respond to PDE5i treatment. Therefore, new treatment methods are needed. In this study...
Main Authors: | Mintao Ji, Dongsheng Chen, Yinyin Shu, Shuai Dong, Zhisen Zhang, Haimeng Zheng, Xiaoni Jin, Lijun Zheng, Yang Liu, Yifei Zheng, Wensheng Zhang, Shiyou Wang, Guangming Zhou, Bingyan Li, Baohua Ji, Yong Yang, Yongde Xu, Lei Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-39009-z |
Similar Items
-
YAP/TAZ Related BioMechano Signal Transduction and Cancer Metastasis
by: Bridget Martinez, et al.
Published: (2019-10-01) -
The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
by: Taha Azad, et al.
Published: (2019-05-01) -
Nuclear Import and Export of YAP and TAZ
by: Michael Kofler, et al.
Published: (2023-10-01) -
Mechanisms of YAP/TAZ transcriptional control
by: Giusy Battilana, et al.
Published: (2021-10-01) -
Roles of Hippo–YAP/TAZ signalling in intervertebral disc degeneration
by: Shi Zheng-wei, et al.
Published: (2023-03-01)